NCT07219173
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07219173
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07219173
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE2
- Indication
- Asthma
- Status
- RECRUITING
- Start date
- 2025-10-22
- Primary completion
- 2028-04
- Registered countries
- Argentina, Brazil, Canada, China, France, Germany, India, Japan, Mexico, Netherlands, Poland, United States
- Sites
- 121
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-09-28
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country. Added 2026-09-28 from the Issue 16 collection: the record was updated in the 21 to 28 September window (LastUpdatePostDate 2026-09-22). No CTIS number on the record.
Company
Through brenipatide (LY3537031): Lilly
Cited in
No published issue cites this registry number.